Melanoma proteomics suggests functional differences related to mutational status
نویسندگان
چکیده
منابع مشابه
Correlation between BRAF mutational status and clinical response to pembrolizumab in advanced melanoma patients
Background About 50% of melanoma (MM) have BRAF V600 mutation and BRAF inhibitors, such as vemurafenib and dabrafenib, have shown an high response rate (RR) and overall survival (OS) improvement in BRAF-mutated MM patients (pts). Pembrolizumab, a monoclonal antibody anti-PD-1, has shown a significant improvement in RR and OS as well, in both MM pts naïve and previously treated with ipilimumab. ...
متن کاملFunctional proteomics.
BACKGROUND With the increase in the number of genome sequencing projects, there is a concomitant exponential growth in the number of protein sequences whose function is still unknown. Functional proteomics constitutes an emerging research area in the proteomic field whose approaches are addressed towards two major targets: the elucidation of the biological function of unknown proteins and the d...
متن کاملMarital Status and Physical Health: Racial Differences
Background and aims: As suggested by the Minorities’ Diminished Return Theory, the associationbetween socioeconomic status and health is weaker for racial and ethnic minorities compared toWhites. The current study compared Blacks and Whites in terms of the association between maritalstatus and physical health.Methods: The State of the State Survey (SOSS) included 881 adu...
متن کاملAge-related differences in white matter integrity and cognitive function are related to APOE status
While an extensive literature is now available on age-related differences in white matter integrity measured by diffusion MRI, relatively little is known about the relationships between diffusion and cognitive functions in older adults. Even less is known about whether these relationships are influenced by the apolipoprotein (APOE) ε4 allele, despite growing evidence that ε4 increases cognitive...
متن کاملA mutational signature in gastric cancer suggests therapeutic strategies
Targeting defects in the DNA repair machinery of neoplastic cells, for example, those due to inactivating BRCA1 and/or BRCA2 mutations, has been used for developing new therapies in certain types of breast, ovarian and pancreatic cancers. Recently, a mutational signature was associated with failure of double-strand DNA break repair by homologous recombination based on its high mutational burden...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Scientific Reports
سال: 2019
ISSN: 2045-2322
DOI: 10.1038/s41598-019-43512-z